MOCHIDA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,190 JPY | -0.47% |
|
+2.41% | -2.45% |
| 04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| 03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Chart calendar Mochida Pharmaceutical Co., Ltd.
7f164e91be2169155ab8552e9a7e928.fqoK8Fr5fpEJ9Wl0v8xEKFo5trEb5GCWB6Nw7ZB3ueQ.MsNppG6LNNVs2BoG9II2WQpRz4N30TDFZeYSiPUFw48hzn6VEpQ_-W2wIA~05edf358101a178559ac14c471eb8b6c
Upcoming events on Mochida Pharmaceutical Co., Ltd.
Past events on Mochida Pharmaceutical Co., Ltd.
| 27/03/2024 | Final dividend |
| 04/02/2024 | Q3 2023 Earnings Release |
| 01/11/2023 | Q2 2023 Earnings Release |
| 27/09/2023 | Ex-dividend day for dividende intermédiaire |
| 03/08/2023 | Q1 2023 Earnings Release |
| 29/06/2023 02:00 | Shareholders Meeting |
| 14/05/2023 | Q4 2022 Earnings Release |
| 29/03/2023 | Ex-dividend day for final dividend |
| 05/02/2023 | Q3 2022 Earnings Release |
| 03/11/2022 | Interim 2022 Earnings Release |
| 28/09/2022 | Ex-dividend day for dividende intermédiaire |
| 31/07/2022 | Q1 2022 Earnings Release |
| 29/06/2022 02:00 | Annual General Meeting |
| 12/05/2022 | FY 2021 Earnings Release |
| 29/03/2022 | Ex-dividend day for final dividend |
| 03/02/2022 | Q3 2022 Earnings Release |
| 04/11/2021 | Interim 2021 Earnings Release |
| 28/09/2021 | Ex-dividend day for dividende intermédiaire |
| 29/07/2021 | Q1 2021 Earnings Release |
| 13/05/2021 | FY 2020 Earnings Release |
Past dividends on Mochida Pharmaceutical Co., Ltd.
| 27/03/2024 | Final Payment 40 JPY |
| 27/09/2023 | Interim Payment 40 JPY |
| 29/03/2023 | Final Payment 40 JPY |
| 28/09/2022 | Interim Payment 40 JPY |
| 29/03/2022 | Final Payment 50 JPY |
| 28/09/2021 | Interim Payment 40 JPY |
| 29/03/2021 | Final Payment 50 JPY |
| 28/09/2020 | Interim Payment 40 JPY |
| 29/03/2020 | Final Payment 40 JPY |
| 26/09/2019 | Interim Payment 40 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 109 643 111 500 -1.67% | 101 799 101 700 0.1% | 102 995 102 500 0.48% | 110 179 109 500 0.62% | 103 261 106 500 -3.04% | 102 000 |
|
EBITDA Million JPY | Released Forecast Spread | 13 507 11 900 13.5% | 11 538 11 400 1.21% | 14 745 13 200 11.7% | 17 081 15 700 8.8% | 11 179 12 100 -7.61% | 8 300 |
|
EBIT Million JPY | Released Forecast Spread | 10 590 9 500 11.47% | 8 807 8 700 1.23% | 12 003 10 500 14.31% | 14 392 13 000 10.71% | 8 507 9 500 -10.45% | 5 500 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 11 642 11 400 2.12% | 6 273 6 000 4.55% | 11 900 10 700 11.21% | 14 591 13 200 10.54% | 9 044 9 750 -7.24% | 5 600 |
|
Net income Million JPY | Released Forecast Spread | 8 435 8 300 1.63% | 4 598 4 500 2.18% | 8 587 7 700 11.52% | 10 569 9 500 11.25% | 6 649 7 100 -6.35% | 4 400 |
|
EPS JPY | Released Forecast Spread | 213 211 0.89% | 118 115 1.87% | 222 200 11.15% | 277 250 11% | 179 193 -7.1% | 124 |
| Announcement Date | 13/05/19 | 15/05/20 | 14/05/21 | 13/05/22 | 15/05/23 | - |
Quarterly results
| Fiscal Period | März | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 51 512 50 200 2.61% | 51 623 52 800 -2.23% | 54 009 50 900 6.11% | 30 805 28 591 7.74% | 25 365 24 686 2.75% | 27 692 28 400 -2.49% | 25 508 25 508 0% | 53 200 53 200 0% | 28 194 28 900 -2.44% | 21 867 25 106 -12.9% | 24 747 25 700 -3.71% | 24 729 25 053 -1.29% | 49 476 49 800 -0.65% | 28 742 27 200 5.67% | 23 782 |
|
EBIT Million JPY | Released Forecast Spread | 6 200 5 000 24% | 7 229 6 400 12.95% | 6 131 5 600 9.48% | 6 914 3 869 78.7% | 1 347 -45,0 3093.33% | 4 265 3 400 25.44% | 1 014 1 535 -33.94% | 5 279 5 800 -8.98% | 5 077 4 521 12.3% | -1 849 -856 -116% | 2 515 2 600 -3.27% | 1 437 185 676.76% | 3 952 2 700 46.37% | 1 839 4 300 -57.23% | -291 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 6 366 | 7 353 | 6 793 | 6 964 | 4 414 | 5 412 | 5 195 | 2 572 | 4 049 | 1 994 | |||||
|
Net income Million JPY | Released Forecast Spread | 4 592 3 850 19.27% | 5 411 4 700 15.13% | 4 916 4 176 17.72% | 5 264 2 468 113.29% | 389 -680 157.21% | 3 155 2 628 20.05% | 768 1 225 -37.31% | 3 923 4 380 -10.43% | 4 158 3 450 20.52% | -1 432 -981 -45.97% | 1 688 1 944 -13.17% | 1 150 328 250.61% | 2 838 2 016 40.77% | 1 606 3 168 -49.31% | -44,0 |
|
EPS JPY | Released Forecast Spread | 117 | 140 | 128 | 138 | 84,0 | 105 | 112 | 46,2 | 78,4 | 45,1 | |||||
| Announcement Date | 05/11/19 | 02/11/20 | 05/11/21 | 04/02/22 | 13/05/22 | 01/08/22 | 04/11/22 | 04/11/22 | 06/02/23 | 15/05/23 | 04/08/23 | 02/11/23 | 02/11/23 | 05/02/24 | - |
More events
Past sector events for Mochida Pharmaceutical Co., Ltd.
| Today 11:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| Today | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| Today | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 21:01 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 18:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 01/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4534 Stock
- Calendar Mochida Pharmaceutical Co., Ltd.
